No valuation for ROSE Diagnostics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($3.4M) and the funding record below are the closest available signals.
- ·Watch ROSE Diagnostics: the Monday email on marks, rounds and moves
ROSE Diagnostics funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2025 | Seed Round | $2.3M | ▮ | ▮ |
| Jun 2024 | Seed Round | $1.0M | ▮ | ▮ |
Membership and data by Private Market View
How much has ROSE Diagnostics raised?
ROSE Diagnostics has raised $3.4 million across 2 recorded rounds since 2024. The largest was a $2.3 million seed round in May 2025.
ROSE Diagnostics has filed 2 Form Ds with the SEC since 2024, most recently in May 2025 ($2.3 million sold to 18 investors).
How ROSE Diagnostics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For ROSE Diagnostics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about ROSE Diagnostics
- How much has ROSE Diagnostics raised?
- ROSE Diagnostics has raised $3.4M in total funding across 2 recorded rounds.
- When did ROSE Diagnostics last raise?
- ROSE Diagnostics last raised in May 2025 (Seed Round), raising $2.3M.